Sponsor or institution
Clinical trials and research at Sumitomo Pharma America, Inc.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Sumitomo Pharma America, Inc. that are recruiting, at sites in 14 countries (most in United States (5), Japan (3), Belgium (2)). By phase: Phase 1/2 (5). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 14Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safety of a one-time DSP-3077 retinal sheet injection in adults with retinitis pigmentosa | Phase 1/2 | Boston, Massachusetts and 1 other locations | Recruiting | Mar 24, 2025 |
| Evaluating the safety and effects of DSP-1083 in Parkinson's disease patients | Phase 1/2 | La Jolla, California and 2 other locations | Recruiting | Dec 31, 2024 |
| SMP-3124LP treatment for adults with advanced solid tumors | Phase 1/2 | Los Angeles, California and 12 other locations | Recruiting | Jul 30, 2024 |
| Testing Enzomenib for patients with relapsed or refractory acute leukemia | Phase 1/2 | Newport Beach, California and 103 other locations | Recruiting | Aug 3, 2021 |
| Oral Nuvisertib for Patients with Myelofibrosis | Phase 1/2 | Birmingham, Alabama and 90 other locations | Recruiting | Nov 25, 2019 |
All recruiting trials (5)
-
Safety of a one-time DSP-3077 retinal sheet injection in adults with retinitis pigmentosa
This will test whether a single subretinal injection of DSP-3077 retinal sheets is safe and well tolerated in adults with retinitis pigmentosa.
-
Evaluating the safety and effects of DSP-1083 in Parkinson's disease patients
This study is testing a new treatment called DSP-1083 to see if it can safely help people with Parkinson's disease feel better over two years.
-
SMP-3124LP treatment for adults with advanced solid tumors
This study is testing a new treatment called SMP-3124LP to see if it can help adults with advanced solid tumors, like certain types of ovarian and breast cancer, feel better and improve their condition.
-
Testing Enzomenib for patients with relapsed or refractory acute leukemia
This study is testing a new drug called Enzomenib to see if it can help adults with relapsed or hard-to-treat acute leukemia feel better.
-
Oral Nuvisertib for Patients with Myelofibrosis
This study is testing a new oral medication called nuvisertib to see if it can help people with myelofibrosis who haven't had success with other treatments.
Quick answers
How many clinical trials run by Sumitomo Pharma America, Inc. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (5 trials), Japan (3 trials), Belgium (2 trials), Canada (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 5. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.